IST PARK houses a growing community of technology startups, entrepreneurs, and biotech companies. Visit us at one of our public events to get in touch.
Yesterday afternoon, Federal Chancellor Birgitte Bierlein visited the Institute of Science and Technology Austria (IST Austria) in Klosterneuburg. Together with IST Austria President Thomas A. Henzinger and […]
Lower Austria’s research and technology landscape is growing: On September 30th, the new technology and research center, IST Park, opened in Klosterneuburg, after one and a half […]
Advances in science and technology over the past few decades have allowed physicists to study nature at an increasingly finer scale. As the study of natural systems […]
Companies located at IST Park
Crystalline Mirror Solutions manufactures low-noise reflective optics using a proprietary coating technology. CMS was founded as a spin-off of fundamental physics research at the University of Vienna by Dr. Garrett Cole and Dr. Markus Aspelmeyer.
PRIME Aerostructures is an Austrian engineering company with a strong focus on the design, simulation and fabrication of state-of-the-art aviation and aerospace components.
IST Cube is a new seed fund based
at the Institute of Science and Technology in
Austria. IST CUBE focuses on startups with a
background in deep tech and science, and offers
a dedicated curriculum for entrepreneurs, access
to a thriving research institute, and financial
IST Cube startups located at IST PARK
VALANX Biotech develops a novel site-specific protein conjugation platform to enable a fast and cost-effective creation of antibody drug conjugates, as well as peptide conjugates and oriented immobilisation for biosensors. VALANX Biotech will receive hands-on support by the newly-established IST CUBE incubator, and has recently moved to a lab bench in the Bertalanffy Foundation building. Additionally, VALANX is among the top 10 selected nominees for the Best of Biotech 2017 award.
Ribbon Synthetic Biolabs aims to deliver purpose-built genetic solutions for the current and upcoming synthetic biology challenges. We overcome the limitations faced by
DNA chemical synthesis and conventional cloning providing customized, agile, top-notch solutions that cover high-throughput requirements in synthetic DNA. Our approach defines new standards of molecular biology making some existing technologies obsolete.
Interested in becoming a part of IST Park?
We are looking forward to your inquiry!